Editors:
- Gives an update of the multi-layered facets of the “designer drugs” phenomenon that exploded into public’s consciousness in the 2010s
- Offers diverse perspectives in areas of neuropharmacology, analytical toxicology, epidemiology of adverse events and information-exchange
- Provides accurate information about psychoactive recreational substances that transcended ‘traditional’ drugs of abuse
Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 252)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (18 chapters)
-
Front Matter
About this book
Editors and Affiliations
-
Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, Homburg (Saar), Germany
Hans H. Maurer
-
School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK
Simon D. Brandt
Bibliographic Information
Book Title: New Psychoactive Substances
Book Subtitle: Pharmacology, Clinical, Forensic and Analytical Toxicology
Editors: Hans H. Maurer, Simon D. Brandt
Series Title: Handbook of Experimental Pharmacology
DOI: https://doi.org/10.1007/978-3-030-10561-7
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Nature Switzerland AG 2018
Hardcover ISBN: 978-3-030-10560-0Published: 06 March 2019
eBook ISBN: 978-3-030-10561-7Published: 20 February 2019
Series ISSN: 0171-2004
Series E-ISSN: 1865-0325
Edition Number: 1
Number of Pages: X, 566
Number of Illustrations: 62 b/w illustrations, 28 illustrations in colour
Topics: Pharmacology/Toxicology